In anticipation of continued increased demand for zinc lozenges worldwide, Ohad Cohen, chief executive officer of Israel-based Gadot Biochemical Industries, has announced that the company is ready to fulfill requirements for zinc gluconate, the preferred winter form of zinc and the form best utilized in lozenges to treat the common cold, he said.
Zinc is an essential trace element that is vital for the healthy function of the immune system. It acts as a cofactor for numerous enzymes, including those involved in DNA and RNA replication, protein synthesis, insulin production and brain development. Because the human body cannot store excess zinc and regular supply from food is not sufficient, continuous dietary intake is required.
If zinc intake needs are not met, deficiency can occur, mainly compromising the healthy function of the immune system. Research shows that zinc is needed to activate several types of white blood cells. Supplementing with zinc gluconate helps white blood cells to proliferate, boosting immune function.
According to Christine Bailey, MSc BSc Nutrition, PGCE, an award-winning UK-based registered nutritionist and healthy eating expert, zinc prevents viruses from attaching to cells in the nasal passage and therefore stops them from entering the body as told to Get The Gloss, an online destination for expert health and beauty information.
The U.S. Food and Drug Administration (FDA) has approved zinc gluconate as generally recognized as safe (GRAS) for food additives. Therefore, usage of zinc gluconate in end-user industries such as nutraceutical and pharmaceutical, has increased across the globe. Technological advancements have provided major breakthroughs for utilization of zinc gluconate.
“Immunity is the most top-of-mind health concern globally,” Cohen stated. “There are questions about supply and availability of some varied immune-support ingredients, but we can assure that our zinc gluconate is readily available for the increased demand.”
For more information visit www.gadotbio.com.
